artemether has been researched along with pyrimethamine in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.93) | 18.7374 |
1990's | 10 (17.86) | 18.2507 |
2000's | 23 (41.07) | 29.6817 |
2010's | 14 (25.00) | 24.3611 |
2020's | 4 (7.14) | 2.80 |
Authors | Studies |
---|---|
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Beck, HP; Brun, R; Cohen, SB; Dartois, V; Dharia, NV; Diagana, TT; Fidock, DA; Goh, A; González-Páez, GE; Jegla, T; Keller, TH; Lakshminarayana, SB; Lee, MC; McNamara, C; Nosten, F; Plouffe, DM; Renia, L; Rottmann, M; Russell, B; Schmitt, EK; Seitz, P; Spencer, KR; Suwanarusk, R; Tan, J; Winzeler, EA; Yeung, BK; Zou, B | 1 |
Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
Beale, GH; Thaithong, S | 1 |
Cai, XZ; He, XZ; Yang, XP; Ye, BS; Zhan, WC; Zhan, X | 1 |
Adio, R; Oduola, AM; Omokhodion, SJ; Salako, LA; Sowunmi, A; Walker, O | 1 |
Kanda, T; Karbwang, J; Na-Bangchang, K; Suprakob, K; Tan-ariya, P; Thanavibul, A; Tipwangso, P | 1 |
Oduola, AM; Sowunmi, A | 2 |
Falade, CO; Fehintola, FA; Kyle, DE; Makler, MT; Milhous, WK; Oduola, AM; Ogundahunsi, OA; Omitowoju, GO; Piper, RC; Schuster, BG; Sowunmi, A | 1 |
Bojang, K; Doherty, T; Gathmann, I; Gemperli, B; Greenwood, B; Haywood, M; Jaffar, S; Jones, P; McAdam, K; Obaro, S; Pinder, M; Royce, C; Snounou, G; von Seidlein, L | 1 |
Karbwang, J; Na-Bangchang, K; Tan-ariya, P; Thanavibul, A; Thipawangkosol, P; Ubalee, R | 1 |
Karbwang, J; Na-Bangchang, K; Tan-ariya, P; Ubalee, R | 1 |
Björkman, A; Hassan Alin, M; Wernsdorfer, WH | 1 |
Fusai, T; Mosnier, J; Parzy, D; Pradines, B; Rogier, C; Spiegel, A; Tall, A; Trape, JF | 1 |
Congpuong, K; Karbwang, J; Na-Bangchang, K; Sirichaisinthop, J; Tippawangkosol, P; Ubalee, R | 1 |
Dalvi, SS; Gogtay, NJ; Kshirsagar, NA; Rajgor, D; Wakde, M | 1 |
Ishiyama, A; Kohana, A; Manabe, C; Omura, S; Otoguro, K; Shiomi, K; Ui, H; Yamada, H | 1 |
Majori, G | 1 |
Garner, P; Omari, A | 1 |
Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
Garner, P; Jones, K; Taylor-Robinson, D | 1 |
Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
Brun, R; Charman, SA; Dorn, A; Maerki, S; Matile, H; Wittlin, S | 1 |
Hi, YC; Huang, F; Tang, LH; Wang, QM | 1 |
Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
Chalwe, V; Chilengi, R; D'Alessandro, U; Dujardin, JC; Moerman, F; Mulenga, M; Mwananyanda, L; Van Overmeir, C; VangGeertruyden, JP | 1 |
Chalwe, V; Chilengi, R; Colebunders, R; D'Alessandro, U; Dujardin, JC; Kasongo, W; Kestens, L; Moerman, F; Mulenga, M; Mwananyanda, L; Van Geertruyden, JP; Van Overmeir, C | 1 |
Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y | 1 |
Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
Ayede, I; Dada-Adegbola, HO; Fadero, FF; Falade, AG; Falade, CO; Gbotosho, GO; Happi, CT; Oduola, AM; Salako, LA | 1 |
Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
Nyunt, MM; Plowe, CV | 1 |
Adedeji, AA; Balogun, T; Bolaji, OM; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
Oguonu, T; Okafor, HU; Shu, EN | 1 |
Dokomajilar, C; Greenhouse, B; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, YY; Somé, AF; Zongo, I | 1 |
Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
Arguin, PM; Doney, AC; Galev, A; Green, M; Kapella, BK; Mekonnen, L; Phares, CR; Stauffer, WM; Weinberg, M | 1 |
Mannemala, SS; Nagarajan, JS | 1 |
Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
Ahmed, I; ElMohammady, H; Jamil, M; Kakar, Q; Khan, MA; Sheikh, S; Warsame, M | 1 |
Amran, JG; Arale, AM; Barrette, A; Hassan, AH; Hassan, AM; Jibril, AM; Mohamud, SA; Muse, AY; Nada, RA; Warsame, M; Yusuf, FE | 1 |
Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
Al Khaja, KAJ; Sequeira, RP | 1 |
Chenet, SM; Cortés, LJ; Guerra, AP; Lucchi, NW; Macedo de Oliveira, A; Olivera, MJ | 1 |
Abuaku, B; Afrane, Y; Amoah, LE; Cui, L; Duah-Quashie, NO; Duan, M; Huang, Y; Li, X; Pan, M; Qin, Y; Sun, K; Wang, X; Yang, Q; Yang, Z; Zeng, W; Zhao, H; Zhao, W; Zhou, L; Zhu, W | 1 |
Bernieri, F; Cavallari, S; Doderer-Lang, C; Guidetti, C; L'Episcopia, M; Menard, D; Perrotti, E; Priuli, GB; Severini, C | 1 |
6 review(s) available for artemether and pyrimethamine
Article | Year |
---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
20 trial(s) available for artemether and pyrimethamine
Article | Year |
---|---|
Artemether in moderately severe and cerebral malaria in Nigerian children.
Topics: Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1994 |
Artemether-pyrimethamine in the treatment of pyrimethamine-resistant falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Treatment Outcome | 1996 |
Efficacy of artemether in severe falciparum malaria in African children.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1996 |
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1998 |
Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Regression Analysis; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 1998 |
Pharmacokinetic interactions of artemether and pyrimethamine in healthy male Thais.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Cross-Over Studies; Drug Interactions; Humans; Male; Pyrimethamine; Sesquiterpenes; Thailand | 1998 |
Investigations of incidence of pretreatment, drug sensitivity in vitro, and plasma levels of pyrimethamine in patients with multidrug resistant falciparum malaria following the three combination regimens of artemether/pyrimethamine.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Malaria, Falciparum; Microbial Sensitivity Tests; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Statistics, Nonparametric; Thailand | 1999 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Odds Ratio; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Zambia | 2006 |
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; CD4 Lymphocyte Count; Drug Combinations; Ethanolamines; Female; Fluorenes; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome; Zambia | 2006 |
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfalene; Treatment Outcome | 2006 |
Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemeter followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian childr
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Nigeria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Suppositories | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual-stage parasites in falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sulfalene; Survival Rate; Treatment Outcome | 2008 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome | 2010 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
30 other study(ies) available for artemether and pyrimethamine
Article | Year |
---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Spiroindolones, a potent compound class for the treatment of malaria.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Cell Line; Drug Discovery; Drug Resistance; Erythrocytes; Female; Genes, Protozoan; Humans; Indoles; Malaria; Male; Mice; Models, Molecular; Mutant Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Protein Synthesis Inhibitors; Protozoan Proteins; Rats; Rats, Wistar; Spiro Compounds | 2010 |
The combined use of artemether, sulfadoxine and pyrimethamine in the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Sulfanilamides; Time Factors | 1988 |
The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
Topics: Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 1986 |
A case of black water fever treated with peritoneal dialysis and artemether (quinghaosu derivative).
Topics: Artemether; Artemisinins; Blackwater Fever; Humans; Malaria; Middle Aged; Peritoneal Dialysis; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1987 |
Susceptibility of Thai isolates of Plasmodium falciparum to artemisinine (qinghaosu) and artemether.
Topics: Animals; Artemether; Artemisinins; Chloroquine; Drug Combinations; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Thailand | 1985 |
[The combined use of artemether, sulfadoxine, pyrimethamine and primaquine in the treatment of chloroquine-resistant falciparum malaria].
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Primaquine; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1985 |
Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Monitoring, Physiologic; Nigeria; Phenanthrenes; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1997 |
Plasma containing artemether-pyrimethamine has ex vivo blood schizonticidal activity against Plasmodium falciparum.
Topics: Animals; Antimalarials; Area Under Curve; Artemether; Artemisinins; Drug Resistance, Multiple; Humans; Male; Plasmodium falciparum; Pyrimethamine; Reference Values; Sesquiterpenes | 1998 |
Synergism of benflumetol and artemether in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Culture Media; Drug Resistance, Multiple; Drug Synergism; Ethanolamines; Fluorenes; Inhibitory Concentration 50; Lumefantrine; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes | 1999 |
Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.
Topics: Amodiaquine; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimalarials; Artemether; Artemisinins; Chloroquine; Doxycycline; Drug Resistance; Erythrocytes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Scintillation Counting; Senegal; Sesquiterpenes; Statistics, Nonparametric; Triazines | 2000 |
An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; India; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Potent antimalarial activities of polyether antibiotic, X-206.
Topics: Actinomycetales; Animals; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Death; Cell Line; Chloroquine; Drug Resistance; Embryo, Mammalian; Embryo, Nonmammalian; Ethers, Cyclic; Humans; Malaria; Mice; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes | 2001 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Erythrocytes; Heterocyclic Compounds, 1-Ring; Molecular Structure; Peroxides; Plasmodium falciparum; Pyrimethamine; Spiro Compounds | 2006 |
[The microfluorimetric assay (MFA) in in vitro testing the sensitivity of Plasmodium falciparum to antimalarial drugs].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Cytophotometry; Inhibitory Concentration 50; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Reproducibility of Results | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Bacterial; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Recurrence; Sulfadoxine | 2010 |
Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Pyrimethamine; Refugees; Sulfadoxine; Tanzania; United States | 2011 |
Development and validation of a generic liquid chromatographic method for the simultaneous determination of five commonly used antimalarial drugs: Application to pharmaceutical formulations and human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Ethanolamines; Fluorenes; Healthy Volunteers; Humans; Lumefantrine; Mefloquine; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Tablets | 2015 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Male; Mutation; Pakistan; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Sulfadoxine | 2016 |
Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Codon; Colombia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine | 2022 |
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Ghana; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine | 2022 |
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Benin; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |